HP
BDSI

HealthInvest Partners’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

HealthInvest Partners’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,000,000
Closed -$7.82M – 15
2021
Q1 		$7.82M Buy
2,000,000
+425,000
+27% +$1.76M 6.23% 5
2020
Q4 		$6.62M Buy
+1,575,000
New +$6.07M 4.38% 16

Other funds holding BDSI

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

HealthInvest Partners's BDSI Position: Q2 2021 in Review

HealthInvest Partners sold out of BioDelivery Sciences International, Inc. (BDSI) in Q2 2021, closing a stake of 2,000,000 shares — an estimated $7.82M sold.

HealthInvest Partners first reported a position in BDSI in Q4 2020 and held it in 2 quarters. The position peaked at $7.82M in Q1 2021. 143 funds tracked by Wall St. Rank hold BDSI as of Q2 2021.

  • HealthInvest Partners reported no remaining BioDelivery Sciences International, Inc. position as of Q2 2021 after selling out during the quarter.
  • HealthInvest Partners sold 2,000,000 BioDelivery Sciences International, Inc. shares in Q2 2021, an estimated $7.82M.
  • HealthInvest Partners first reported a position in BioDelivery Sciences International, Inc. in Q4 2020 and held it in 2 quarters.
  • HealthInvest Partners's BioDelivery Sciences International, Inc. position peaked at $7.82M in Q1 2021.
  • 143 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q2 2021.

Based on HealthInvest Partners's 13F filing for Q2 2021, filed 10 Aug 2021.